ડૉ. અગ્રવાલની આંખની હૉસ્પિટલ શેરની કિંમત

<h3><span style="font-size:16px;"><strong>Healthcare Facilities company Dr. Agarwal's Eye Hospital announced Q1FY27 results</strong></span></h3><p _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">નાણાંકીય વિશેષતાઓ:</strong></p><ul><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Revenue from Operations:</strong> The company reported revenue from operations of Rs 142.97 crore in Q1FY27, representing a growth of 19.13% on a QoQ basis compared to Rs 120.01 crore in Q4FY26 and a 22.28% increase on a YoY basis compared to Rs 116.92 crore in Q1FY26.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Total Income:</strong> Total income for Q1FY27 stood at Rs 144.93 crore, showing a QoQ increase of 19.21% from Rs 121.58 crore in Q4FY26 and a YoY increase of 23.11% from Rs 117.72 crore in Q1FY26.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Profit Before Tax:</strong> The company achieved a profit before tax of Rs 30.96 crore in Q1FY27, which is a growth of 45.69% over Rs 21.25 crore in Q4FY26 and a 33.51% growth over Rs 23.19 crore in Q1FY26.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Net Profit After Tax:</strong> Net profit for the period reached Rs 23.38 crore in Q1FY27, marking an increase of 43.97% QoQ from Rs 16.24 crore in Q4FY26 and an increase of 35.46% YoY from Rs 17.26 crore in Q1FY26.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">EBITDA:</strong> Earnings before interest, tax, depreciation, and amortisation (EBITDA) reached Rs 45.22 crore in Q1FY27, reflecting a QoQ growth of 28.10% from Rs 35.30 crore in Q4FY26 and a YoY growth of 19.22% from Rs 37.93 crore in Q1FY26.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Total Comprehensive Income:</strong> This parameter stood at Rs 22.91 crore for Q1FY27, compared to Rs 16.38 crore in Q4FY26 and Rs 17.30 crore in Q1FY26.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">શેર દીઠ કમાણી (EPS):</strong> Q4FY26 માં ₹33.60 અને Q1FY26 માં ₹36.72 ની તુલનામાં Q1FY27 માટે બેસિક અને ડાઇલ્યુટેડ EPS ₹48.38 હતું.</li></ul><p _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">બિઝનેસ હાઇલાઇટ્સ</strong>:</p><ul><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Scheme of Amalgamation:</strong> The proposed scheme of amalgamation with its holding company, Dr. Agarwal's Health Care Limited ("AHCL"), received approval from the requisite majority of equity shareholders, secured creditors, and unsecured creditors in meetings held on July 02, 2026. The scheme remains subject to final sanction from the Hon'ble NCLT and other regulatory completions.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Preferential Allotment:</strong> Following the issuance of 1,32,827 equity shares at a price of Rs 5,270 per share (totaling Rs 70 crore) to AHCL in September 2025, the company has utilised Rs 28.20 crore as per the terms of objects approved by shareholders. The balance unutilised portion as of Q1FY27 has been temporarily invested in debt mutual funds.</li><li _ngcontent-ng-c3377174747=""><strong _ngcontent-ng-c3377174747="">Audit Appointment:</strong> The Board has re-appointed M/s. B Y & Associates, Practicing Cost Accountants, as the Cost Auditors for the financial year FY27.</li></ul><p><a class="lb" href="/gujarati/get-document/post/pdf/5761910/" target="_blank">પરિણામની PDF</a></p>

• ટ્રેન્ડલાઇન
• 2 દિવસ 11 કલાક પહેલાં

Reappointment of cost auditors to conduct audit of the cost records of the Company for the financial year 2026-27, is submitted.

• BSE ઇન્ડિયા
• 2 દિવસ 11 કલાક પહેલાં

Unaudited Financial Results for the quarter ended June 30, 2026, is submitted.

• BSE ઇન્ડિયા
• 2 દિવસ 11 કલાક પહેલાં